Is it possible to gain extra waiting time to liver transplantation in acute liver failure patients using albumin dialysis?

Therapeutic Apheresis and Dialysis

Volumn 13, Issue 5, 2009, Pages 413-418

  Koivusalo, Anna Maria ^a   Kantola, Taru ^a,c   Arola, Johanna ^b   Höckerstedt, Krister ^a   Kairaluoma, Pekka ^a   Isoniemi, Helena ^a  

^a Surgical Hospital   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Acute liver failure; Albumin dialysis; Liver transplantation; Molecular Adsorbent Recirculating System

Indexed keywords

ADOLESCENT; ADULT; AGED; ALBUMIN DIALYSIS; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; HEPATIC ENCEPHALOPATHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL DAMAGE; LIVER FAILURE; LIVER GRAFT; LIVER NECROSIS; LIVER TRANSPLANTATION; OVERALL SURVIVAL; PRIORITY JOURNAL; THERAPY DELAY; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ALBUMINS; DIALYSIS; DISEASE PROGRESSION; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MIDDLE AGED; NECROSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 70349787014     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00753.x     Document Type: Article

References (16)

1. Kantola T, Koivusalo A, Höckerstedt K, Isoniemi H. The effect of molecular adsorbent recirculating system on survival, native liver recovery, and need for liver transplantation in acute liver failure patients. Transpl Int 2008 21 : 857.
2. Lahdenperä A, Koivusalo AM, Vakkuri A, Höckerstedt K, Isoniemi H. Value of albumin dialysis therapy in severe liver insufficiency. Transpl Int 2005 17 : 717.
3. Schmidt LE, Tofteng F, Strauss GI, Larsen FS. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy. Scand J Gastroenterol 2004 39 : 974.
4. Loock J, Mitzner SR, Peters E, Schmidt R, Stange J. Amino acid dysbalance in liver failure is favourably influenced by recirculating albumin dialysis (MARS). Liver 2002 22 (Suppl. 2 35.
5. Ben Abraham R, Szold O, Merhav H et al. Rapid resolution of brain edema and improved cerebral perfusion pressure following the molecular adsorbent recycling system in acute liver failure patients. Transplant Proc 2001 33 : 2897.
6. Sorkine P, Ben Abraham R, Szold O et al. Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 2001 29 : 1332.
7. Koivusalo AM, Teikari T, Höckerstedt K, Isoniemi H. Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy. Metab Brain Dis 2008 23 : 387.
8. Brandsaeter B, Hockerstedt K, Friman S et al. Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation-12 years experience in the Nordic countries. Liver Transpl 2002 8 : 1055.
9. Bjoro K, Ericzon BG, Kirkegaard P et al. Highly urgent liver transplantation: possible impact of donor-recipient ABO matching on the outcome after transplantation. Transplantation 2003 75 : 347.
10. Bjoro K, Kirkegaard P, Ericzon BG et al. Is a 3-day limit for highly urgent liver transplantation for fulminant hepatic failure appropriate, and is the diagnosis in some cases incorrect? Transplant Proc 2001 33 : 2511.
11. Schmidt LE, Svendsen LB, Sorensen VR, Hansen BA, Larsen FS. Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure. Liver Transpl 2001 7 : 709.
12. Adam R, Cailliez V, Majno P et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet 2000 356 : 621.
13. The European Liver and Intestinal Transplant Association (ELITA). European Liver Transplant Registry. 2008 Accessed 31 May 2009.] Available from URL: http://www.eltr.org/publi/index-rv.php3
14. Scandiatransplant. Scandiatransplant - a Nordic organ Exchange Organization. 2008 Accessed 31 May 2009.] Available from URL: http://www.scandiatransplant.org/
15. Saliba F, Camus C, Durand F et al. Randomized controlled multicenter trial evaluating the efficacy and safety of albumin dialysis with MARS in patients with fulminant and subfulminant hepatic failure. Hepatology 2008 48 (4 Suppl 377A.
16. Wigg AJ, Gunson BK, Mutimer DJ. Outcomes following liver transplantation for seronegative acute liver failure: experience during a 12-year period with more than 100 patients. Liver Transpl 2005 11 : 27 34.